First Hawaiian Bank Catalyst Pharmaceuticals, Inc. Transaction History

First Hawaiian Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$11.78 - $17.29 $54,541 - $80,052	-4,630 Reduced 14.85%	26,540 $446,000
Q3 2023 Oct 10, 2023	SELL	$11.69 - $15.02 $8,066 - $10,363	-690 Reduced 2.17%	31,170 $364,000
Q2 2023 Jul 06, 2023	SELL	$11.5 - $18.08 $50,370 - $79,190	-4,380 Reduced 12.09%	31,860 $428,000
Q1 2023 Apr 18, 2023	BUY	$14.34 - $21.05 $14,340 - $21,050	1,000 Added 2.84%	36,240 $600,000
Q4 2022 Jan 12, 2023	SELL	$12.25 - $19.5 $197,715 - $314,730	-16,140 Reduced 31.41%	35,240 $655,000
Q1 2022 Apr 06, 2022	BUY	$5.31 - $8.31 $272,827 - $426,967	51,380 New	51,380 $426,000

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.